This compound is a silyl-protected steroid derivative used as a pharmaceutical intermediate in the synthesis of steroid-based active pharmaceutical ingredients. Its structure includes both tert-butyldimethylsilyl and trimethylsilyl protecting groups, which facilitate selective chemical transformations during steroid backbone construction.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 91097-40-4
(17beta)-3-Oxoestra-4,6-dien-17-yl acetate
Pharmaceutical intermediate for steroid synthesis
(8S,13S,14S,17R)-13-Methyl-17-(2-methyl-1,3-dioxolan-2-yl)-1,2,4,6,7,8,12,13,14,15,16,17-dodecahydrospiro(cyclopenta(a)phenanthrene-3,2'-(1,3)dioxolan)-17-ol
Pharmaceutical intermediate for steroid synthesis
Cyclic 3-(1,2-ethanediylacetale)-estra-5(10),9(11)-diene-3,17-dione
Pharmaceutical intermediate for steroid synthesis
Androsta-4,8-diene-3,17-dione
Pharmaceutical intermediate for steroid synthesis
5-bromo-2-methyl-3-nitropyridine
pharmaceutical intermediate
Benzhydryl (6R,7R)-3-(chloromethyl)-7-[(4-methylbenzoyl)amino]-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
beta-lactam antibiotic intermediate
(1R,2S,5S)-6,6-Dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxylic acid
Pharmaceutical intermediate
3-aminoazetidine, 3-boc protected
pharmaceutical intermediate
methyl (4R)-4-[(3R,5S,8S,9S,10S,13R,14S,17R)-3-[tert-butyl(dimethyl)silyl]oxy-10,13-dimethyl-7-trimethylsilyloxy-2,3,4,5,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoate
LLDQVINTBNWOHR-VNCOJPLFSA-N
C[C@H](CCC(=O)OC)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C(=C[C@H]4[C@@]3(CC[C@H](C4)O[Si](C)(C)C(C)(C)C)C)O[Si](C)(C)C)C
—